✦ LIBER ✦

Triple vs dual antiplatelet therapy in ACS: an even contest?

Book ID: 120852785
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200515060-00041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triple antiplatelet therapy vs. dual ant

Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query

✍ Inderjeet Singh; Nusrat Shafiq; Promila Pandhi; Srinivas Reddy; Smita Pattanaik; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 874 KB

AS-247: Triple vs Dual Antiplatelet Ther

AS-247: Triple vs Dual Antiplatelet Therapy in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

✍ Seung Woon Rha; Kang Yin Chen; Yong Jian Li; Kanhaiya Lal Poddar; Yoshiyasu Mina 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 33 KB

An open, randomized, multicenter clinica

An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: A comparison of dual vs. triple drug therapy

✍ Miguel García González; Carlos Pera Madrazo; Ángel Bernardos Rodríguez; Manuel G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

Triple therapy combining an anticalcineurin agent, corticosteroids, and azathioprine (AZA) in liver transplantation has been frequently applied, particularly in Europe. Debates have arisen concerning the use of a third drug (AZA), mainly in patients receiving tacrolimus (TAC). An open-label, multice